Senti Biosciences Holdings (SNTI) Return on Sales (2021 - 2024)
Senti Biosciences Holdings (SNTI) posted quarterly Return on Sales of 0.64% for Q2 2024, up 71.0% year-over-year from 0.37% in Q3 2023, and up 281.58% quarter-over-quarter from 0.17% in Q1 2024.
Senti Biosciences Holdings (SNTI) Return on Sales (2021 - 2024) Analysis & Trends
Senti Biosciences Holdings' Return on Sales history runs 4 years deep, the most recent figure standing at 0.64% for Q2 2024.
- In Q2 2024, Return on Sales rose 71.0% year-over-year to 0.64%; the TTM figure through Jun 2024 stood at 0.64% (up 70.0% YoY), while the FY2025 annual figure was 76.14%, changed N/A from the prior year.
- Return on Sales for Q2 2024 stood at 0.64%, up from 0.17% in the prior quarter.
- The five-year high for Return on Sales was 0.64% in Q3 2023, with the low at 1.45% in Q4 2022.
- The 4-year median for Return on Sales is 0.06% (2023), against an average of 0.16%.
- The sharpest annual moves came in 2022 and 2023: Return on Sales slumped 49 bps in 2022, then surged 150 bps in 2023.
- Senti Biosciences Holdings' Return on Sales stood at 1.04% in 2021, then slumped by 39 bps to 1.45% in 2022, then surged by 104 bps to 0.05% in 2023, then surged by 1100 bps to 0.64% in 2024.
- Business Quant data shows SNTI's Return on Sales at 0.64% in Q2 2024, 0.17% in Q1 2024, and 0.05% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Senti Biosciences Holdings | 12.06 Mn | 12.06 Mn | - | -8.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.64% |
| Mar 31, 2024 | 0.17% |
| Dec 31, 2023 | 0.05% |
| Sep 30, 2023 | 0.64% |
| Jun 30, 2023 | -0.06% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -1.45% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.60% |
| Mar 31, 2022 | -0.11% |
| Dec 31, 2021 | -1.04% |
| Sep 30, 2021 | -0.10% |
| Jun 30, 2021 | -0.12% |